LIFECORE BIOMEDICAL, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount
LIFECORE BIOMEDICAL, INC. (LFCR) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $3.37 million for the 3-month period ending 2024-11-24, per its 10-Q filed 2025-01-02.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2025-01-02
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-11-24 was $3.37M, a 112.88% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2024-08-25 was $2.42M, a 56.98% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2023-11-26 was $1.58M.
- LIFECORE BIOMEDICAL, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2023-08-27 was $1.54M.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month |
|---|---|---|
| 2024-11-24 | $3.37M 10-Q · filed 2025-01-02 | $5.79M 10-Q · filed 2025-01-02 |
| 2024-08-25 | $2.42M 10-Q · filed 2024-10-04 | |
| 2023-11-26 | $1.58M 10-Q · filed 2025-01-02 | $3.13M 10-Q · filed 2025-01-02 |
| 2023-08-27 | $1.54M 10-Q · filed 2024-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |